Maneka Mirchandaney's Stock Ratings

Evercore ISI Group Analyst

Maneka Mirchandaney is an analyst at Evercore ISI Group. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 04/07/2025

Overall Average Return

-28.9%

Smart Score

25.6%

Overall Average Return Percentile

8th

Number of Ratings

12
Buy NowGet Alert
09/11/2023CRNXBuy Now
Crinetics Pharmaceuticals
$26.8978.51%
Maneka Mirchandaney25%
$41 → $48MaintainsOutperformGet Alert
03/22/2023INKTBuy Now
MiNK Therapeutics
$10.50-71.43%
Maneka Mirchandaney25%
$40 → $30MaintainsOutperformGet Alert
02/16/2023SGENBuy Now
Seagen
Maneka Mirchandaney25%
$140 → $175UpgradeIn-Line → OutperformGet Alert
08/03/2022INCYBuy Now
Incyte
$57.5535.53%
Maneka Mirchandaney25%
$90 → $78DowngradeOutperform → In-LineGet Alert
01/10/2022BNOXBuy Now
Bionomics
Maneka Mirchandaney25%
→ $17Initiates → OutperformGet Alert
11/23/2021CRNXBuy Now
Crinetics Pharmaceuticals
$26.89152.88%
Maneka Mirchandaney25%
→ $68Initiates → OutperformGet Alert
11/09/2021INKTBuy Now
MiNK Therapeutics
$10.50185.71%
Maneka Mirchandaney25%
→ $300Initiates → OutperformGet Alert
10/12/2021VRDNBuy Now
Viridian Therapeutics
$11.99233.61%
Maneka Mirchandaney25%
→ $40Initiates → OutperformGet Alert
05/25/2021HOWLBuy Now
Werewolf Therapeutics
$0.733036.93%
Maneka Mirchandaney25%
→ $23Initiates → OutperformGet Alert
05/17/2021SGENBuy Now
Seagen
Maneka Mirchandaney25%
→ $153Initiates → In-LineGet Alert
04/13/2021FNCHBuy Now
Finch Therapeutics Gr
$13.50151.85%
Maneka Mirchandaney25%
→ $1020Initiates → OutperformGet Alert
10/06/2020GBTBuy Now
Global Blood Therapeutics
Maneka Mirchandaney25%
→ $102Initiates → OutperformGet Alert

Recent Analyst Stock Rating News

The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.
Get Started for Free